Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: A randomized controlled trial

Human Reproduction

Volumn 23, Issue 6, 2008, Pages 1355-1358

  Lainas, Trifon G ^a   Sfontouris, Ioannis A ^a   Papanikolaou, Evangelos G ^c   Zorzovilis, John Z ^a   Petsas, George K ^a   Lainas, George T ^a   Kolibianakis, Efstratios M ^b  

^a Eugonia Iatriki Erevna IVF Centre   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Human Reproduction and Genetics Foundation   (Greece)

Author keywords

GnRH agonist; GnRH antagonist; Poor responders

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; TRIPRORELIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OUTCOME ASSESSMENT; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL;

EID: 44449134744     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den107     Document Type: Article

References (21)

1. Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001;16:868-870.
2. Crosignani PG, Ragni G, Lombroso GC, Scarduelli C, de Lauretis L, Caccamo A, Dalpra L, Cavioni V, Cristiani C, Wyssling H et al. IVF: induction of ovulation in poor responders. J Steroid Biochem 1989;32:171-173.
3. De Placido G, Mollo A, Clarizia R, Strina I, Conforti S, Alviggi C. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response. Fertil Steril 2006;85:247-250.
4. Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 2006;13:628-638.
5. Hofmann GE, Toner JP, Muasher SJ, Jones GS. High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization. J In Vitro Fert Embryo Transf 1989;6:285-289.
6. Jenkins JM, Davies DW, Devonport H, Anthony FW, Gadd SC, Watson RH, Masson GM. Comparison of 'poor' responders with 'good' responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization. Hum Reprod 1991;6:918-921.
7. Kolibianakis E, Albano C, Zikopoulos K, Kahn JA, Van Steirteghem A, Devroey P. GnRH antagonists in poor responders. Acta Obstet Gynecol Scand 2004;83:1216-1217.
8. Lainas T, Zorzovilis J, Petsas G, Stavropoulou G, Cazlaris H, Daskalaki V, Lainas G, Alexopoulou E. In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF. Hum Reprod 2005;20:2426-2433.
9. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996;65:961-965.
10. Malmusi S, La Marca A, Giulini S, Xella S, Tagliasacchi D, Marsella T, Volpe A. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation. Fertil Steril 2005;84:402-406.
11. Manzi DL, Thornton KL, Scott LB, Nulsen JC. The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response. Fertil Steril 1994;62:251-256.
12. Martinez F, Coroleu B, Marques L, Perera N, Buxaderas R, Tur R, Barri PN. Comparacion del 'Protocolo Corto' versus 'Antagonistas' con o sin Citrato de Clomifeno para estimulacion en FIV de pacientes con 'baja respuesta'. Revista Iberoamericana de Fertilidad 2003;20:355-360.
13. Mohamed KA, Davies WA, Allsopp J, Lashen H. Agonist 'flare-up' versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril 2005;83:331-335.
14. Mollo A, Clarizia R, Strina I. GnRH antagonist plus hCG versus GnRHa short protocol in patients at risk for poor ovarian response. Hum Reprod 2005;20(Suppl 1):126. (P-348).
15. Pellicer A, Lightman A, Diamond MP, Russell JB, DeCherney AH. Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertil Steril 1987;47:812-815.
16. Pellicer A, Ardiles G, Neuspiller F, Remohi J, Simon C, Bonilla-Musoles F. Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography. Fertil Steril 1998;70:671-675.
17. Schmidt DW, Bremner T, Orris JJ, Maier DB, Benadiva CA, Nulsen JC. A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertil Steril 2005;83:1568-1571.
18. Stadtmauer L, Ditkoff EC, Session D, Kelly A. High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer. Fertil Steril 1994;61:1058-1064.
19. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003;9:61-76.
20. Ubaldi FM, Rienzi L, Ferrero S, Baroni E, Sapienza F, Cobellis L, Greco E. Management of poor responders in IVF. Reprod Biomed Online 2005;10:235-246.
21. Van Rysselberge M, Puissant F, Barlow P, Lejeune B, Delvigne A, Leroy F. Fertility prognosis in IVF treatment of patients with cancelled cycles. Hum Reprod 1989;4:663-666.